Skip to main content

GOLDMAN SACHS GROUP INC

Position in MCRB — Seres Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in MCRB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$120,156
-$93,223 QoQ
Shares Held
15,229
+6.2% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 36 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MCRB Over Time

Shares Held

Position Value (USD)

Derivatives in MCRB

reported options exposure · as of Jun 30, 2022
CallValue
$171,500
CallShares
2,500
PutValue
$171,500
PutShares
2,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,040,380,016 across 360 Biotechnology names. MCRB ranks #329 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MCRB

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $120,156 15,229
2025-12-31 $213,379 14,340
2025-03-31 $52,239 74,629
2024-12-31 $44,001 52,950
2024-09-30 $13,875 14,668
2024-06-30 $482,872 666,951
2024-03-31 $823,641 1,064,137
2023-12-31 $610,206 435,862
2023-09-30 $1,668,052 700,863
2023-06-30 $3,146,043 656,794
2023-03-31 $1,818,640 320,748
2022-12-31 $1,872,600 334,393
2022-09-30 $1,704,708 265,531
2022-06-30 $171,500 50,000
2022-06-30 $171,500 50,000
2022-06-30 $1,617,408 471,548
2022-03-31 $356,000 50,000
2022-03-31 $4,475,268 628,549
2022-03-31 $356,000 50,000
2021-12-31 $10,316,288 1,238,450
2021-09-30 $3,977,744 571,515
2021-06-30 $17,231,839 722,509
2021-03-31 $18,718,780 909,120
2020-12-31 $18,243,067 744,615
2020-09-30 $13,843,590 489,000
2020-09-30 $2,621,732 92,608
2020-06-30 $1,744,106 366,409
2020-03-31 $594,665 166,573